Scarica l'app Stockscreener
118.42
3.69%
-4.54
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AXSM Giù?
Forum
Previsione
Axsome Therapeutics Inc Borsa (AXSM) Ultime notizie
Scientech Research LLC Makes New Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Investor Alert: Class Action Lawsuits Against General Motors, DocGo, Estée Lauder, and Axsome Therapeutics Survive Motions to Dismiss — Johnson Fistel, PLLP Encourages Shareholders to Contact the Firm - GlobeNewswire
Vident Advisory LLC Acquires New Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Adage Capital Partners GP L.L.C. Sells 12,000 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Woodline Partners LP Cuts Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Fred Alger Management LLC Takes $860,000 Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome initiated with Overweight at Wells Fargo on Alzheimer's drug potential - MSN
Axsome Therapeutics (NASDAQ:AXSM) Director Purchases $200,466.00 in Stock - MarketBeat
Axiom Investors LLC DE Invests $3.07 Million in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome therapeutics director Coleman buys $200k+ in shares - Investing.com India
Axsome therapeutics director Coleman buys $200k+ in shares By Investing.com - Investing.com Australia
Axsome Therapeutics, Inc. $AXSM Shares Sold by Cormorant Asset Management LP - MarketBeat
Ieq Capital LLC Takes Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Will Axsome Therapeutics Inc. announce a stock splitJuly 2025 Sector Moves & Low Risk High Win Rate Picks - Lancaster City Council
Axsome Therapeutics at Morgan Stanley: Strategic Growth and Innovation By Investing.com - Investing.com Canada
Axsome Therapeutics at Morgan Stanley: Strategic Growth and Innovation - Investing.com
Sector ETF Data Correlates with Strength in Axsome Therapeutics Inc.2025 Performance Recap & Safe Entry Point Identification - beatles.ru
Roger Jeffs Sells 13,464 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock - MarketBeat
Axsome Therapeutics, Inc. $AXSM is BVF Inc. IL's 2nd Largest Position - MarketBeat
Point72 Europe London LLP Has $1.76 Million Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Russell Investments Group Ltd. Has $308,000 Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
PDT Partners LLC Increases Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeat
What does recent volatility data suggest for Axsome Therapeutics Inc2025 Key Lessons & Reliable Breakout Forecasts - Newser
What does recent volatility data suggest for Axsome Therapeutics Inc.July 2025 Analyst Calls & Weekly Stock Breakout Alerts - Newser
Axsome therapeutics director Saad sells $1.14 million in shares By Investing.com - Investing.com Australia
Axsome therapeutics director Saad sells $1.14 million in shares - Investing.com
Ranking Axsome Therapeutics Inc. among high performing stocks via toolsQuarterly Profit Review & High Accuracy Buy Signal Tips - Newser
Applying big data sentiment scoring on Axsome Therapeutics Inc.July 2025 PreEarnings & Weekly High Momentum Picks - Newser
Landscape Capital Management L.L.C. Makes New $632,000 Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Published on: 2025-09-05 14:08:02 - Newser
Is Axsome Therapeutics Inc. a stock for growth or value investorsWeekly Profit Recap & High Conviction Buy Zone Picks - خودرو بانک
Best data tools to analyze Axsome Therapeutics Inc. stockTrade Signal Summary & Technical Pattern Alert System - Newser
Using AI based signals to follow Axsome Therapeutics Inc.July 2025 Pullbacks & Weekly High Return Opportunities - Newser
Why Axsome Therapeutics Inc. is moving today2025 Historical Comparison & Smart Investment Allocation Tips - Newser
Custom watchlist performance reports with Axsome Therapeutics Inc.Weekly Investment Report & Fast Entry Momentum Alerts - Newser
Multi asset correlation models including Axsome Therapeutics Inc.Earnings Trend Report & High Conviction Investment Ideas - Newser
Axsome Therapeutics at Cantor Conference: Strategic Growth in Brain Health By Investing.com - Investing.com Canada
Driehaus Capital Management LLC Makes New Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Is Axsome Therapeutics Inc.’s growth already priced inCPI Data & Safe Swing Trade Setup Alerts - khodrobank.com
Prediction: These 2 Biotech Stocks Could Double in the Next 5 Years - The Globe and Mail
Will Axsome Therapeutics Inc. bounce back from current supportWeekly Gains Summary & High Return Trade Opportunity Guides - Newser
Forecasting Axsome Therapeutics Inc. price range with options dataJuly 2025 Review & Weekly High Potential Alerts - Newser
Wells Fargo Initiates Coverage on Axsome Therapeutics with Overweight Rating and $163 Price Target - AInvest
Relative strength of Axsome Therapeutics Inc. in sector analysisQuarterly Portfolio Review & Long-Term Safe Investment Plans - Newser
Sector ETF performance correlation with Axsome Therapeutics Inc.Volume Spike & Proven Capital Preservation Methods - Newser
0.93%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):